Common resistance

Credit: left: Jim Dowdalls / Photo Researchers, Inc." /> Credit: left: Jim Dowdalls / Photo Researchers, Inc. The paper: N. Houstis et al., "Reactive oxygen species have a causal role in multiple forms of insulin resistance," Nature, 440:944—8, 2006. (Cited in 109 papers) The finding: Evan Rosen, from Beth Israel Deaconess Medical Center in Boston, and other colleagues tested whether a common mechanism

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

N. Houstis et al., "Reactive oxygen species have a causal role in multiple forms of insulin resistance," Nature, 440:944—8, 2006. (Cited in 109 papers)

Evan Rosen, from Beth Israel Deaconess Medical Center in Boston, and other colleagues tested whether a common mechanism underlies the various stimuli that cause cells to become insulin resistant. Using transcriptional profiling in mouse cell culture, they found about 80 gene changes common between two stimuli (mouse tumor necrosis factor [TNF] and the glucocorticoid dexamethasone), most of them relating to reactive oxygen species (ROS) activities.

The authors also observed in cell culture and in mice that increased ROS levels prompted insulin resistance, and lower ROS levels reduced resistance by roughly 50%. "This paper was the first convincing, comprehensive evidence that reactive oxygen species cause insulin resistance," says James Meigs at Massachusetts General Hospital.

Meigs and his colleagues took data from the Framingham Offspring Study and found ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies